Moderna, Novavax Developing Combined Single-Dose COVID-19 and Influenza Vaccine
American pharmaceutical and biotechnology company Moderna, Inc., which partnered with the U.S. National Institutes of Allergy and Infectious Diseases (NIAID) to develop an mRNA COVID-19 vaccine being distributed in the United States under an Emergency Use Authorization (EUA) announced that it is developing a combined single-dose booster vaccine for COVID-19 and seasonal influenza.1 In a […]
COVID Vaccines Not Proven to Prevent SARS-CoV-2 Infection or Transmission
After analyzing data from a July 2021 Provincetown, Massachusetts COVID-19 outbreak where 74 percent of those infected and diagnosed were fully vaccinated, the U.S. Centers for Disease Control and Prevention (CDC) announced last month that vaccinated individuals can become infected with the SARS-CoV-2 virus and transmit it to others. Expressing “alarm” at this new information, the government agency in charge of protecting the public health doubled down on imperatives for a return to masking, including for the vaccinated, and more vaccination.
Moderna Expects $18.4 Billion in Sales from Its COVID-19 Vaccine This Year
Moderna, Inc. expects to generate $18.4 billion from sales of its experimental mRNA-1273 COVID-19 vaccine being distributed in the U.S. under an Emergency Use Authorization (EUA) granted by the Food and Drug Administration (FDA). This will be the first time that the U.S. based pharmaceutical company will make a profit since it was established in […]
Who is Getting Rich Off Coronavirus Pandemic?
Opinion | In May 2020, the U.S. unemployment rate was 13.3%,1 which means 21 million Americans were unemployed. Not surprisingly, financial stress is a major concern, with 88% of Americans surveyed by the National Endowment for Financial Education (NEFE) saying that the COVID-19 pandemic is creating stress for their personal financial situation.2 Fifty-four percent were particularly […]